NBSE   $0.378  -1.56% Market Open

NeuBase Therapeutics Inc
Total Cash 12.57M
totalCashPerShare 3.371
EBITDA -23.41M
Total Debt 5.34M
quickRatio 7.211
currentRatio 7.403
Total Revenue
debtToEquity 58.393
Revenue/Share
ROA -0.43032002
ROE -0.93461996
grossProfits
freeCashflow -15.18M
operatingCashflow -24.69M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue -5.68M
forwardPE
floatShares 3.30M
sharesOutstanding 3.75M
sharesShort 149.12K
sharesShortPriorMonth 199.81K
dateShortInterest
sharesPercentSharesOut 0.04%
heldPercentInsiders 0.13%
heldPercentInstitutions 0.13%
Short Ratio help_outline 0.60%
shortPercentOfFloat 0.04%
impliedSharesOutstanding
bookValue 2.45
Price To Book help_outline 0.17
earningsQuarterlyGrowth
netIncomeToCommon -24.59M
trailingEps -18.60%
forwardEps -11.40%
enterpriseToEbitda 0.24
lastDividendValue
lastDividendDate
currentQuarterEstimate 4Q 2023
institutionsCount 25
lastUpdated April 16, 2024, 4:24 p.m.